Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/5/26 16:05 | 2/4/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Inrig Jula | CA | O | Chief Me | 5 | S.dm | -1,143 | 27.74 | 0 | -41 | 107 | D | |||||||||||||||
2/5/26 16:05 | 2/4/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Cline Christopher R. | CA | O | CFO | 4 | S.d | -1,314 | 26.81 | 0 | -49 | 113 | D | |||||||||||||||
2/5/26 16:05 | 2/4/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Reed Elizabeth E | CA | O | GC,GC | 4 | S.d | -791 | 26.22 | 0 | -30 | 108 | D | |||||||||||||||
2/3/26 21:30 | 2/3/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Dube Eric M | CA | DO | CEO | 3 | S.dm | -5,963 | 27.09 | 0 | -220 | 433 | D | |||||||||||||||
2/3/26 21:30 | 2/3/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Heerma Peter | CA | O | Chief Co | 2 | S.d | -434 | 35.31 | 0 | -12 | 132 | D | |||||||||||||||
2/3/26 21:30 | 2/3/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Rote William E. | CA | O | Chief Re | 3 | S.d | -4,052 | 30.59 | 0 | -132 | 109 | D | |||||||||||||||
2/3/26 21:30 | 2/3/26 | TVTX | Health | Drug | Pharmaceutical Preparations | Calvin Sandra | CA | O | SVP,Chie | 3 | S.d | -540 | 36.87 | 0 | -15 | 49 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |